Here are relevant reports on : same-day-delivery-market
-
Hydrogen Generation Market by Technology (SMR, ATR, POX, Coal Gasification, Electrolysis), Application (Refinery, Ammonia, Methanol, Transportation, Power Generation), Source (Blue, Green, Gray), Generation & Delivery Mode, Region - Global Forecast to 2030
The hydrogen generation market is projected to grow from USD 157.81 billion in 2025 to USD 226.37 billion by 2030 at a CAGR of 7.5% during the forecast period. Some major players in the hydrogen generation market are Linde plc (Ireland), Air Liquide (France), Saudi Arabian Oil Co. (Saudi Arabia), Air Products and Chemicals, Inc. (US), Shell plc (UK), ENGIE (France), Chevron Corporation (US), Ørsted A/S (Denmark), and Messer SE & Co. KGaA (Germany). Major strategies adopted by these players include acquisitions, sales contracts, collaboration, investments, agreements, partnerships, and expansions.
- Published: July 2025
- Price: $ 7150
- TOC Available:
-
Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) & Region - Global Forecast to 2030
The global injectable drug delivery market, valued at US$633.77 billion in 2024, stood at US$690.23 billion in 2025 and is projected to advance at a resilient CAGR of 8.4% from 2025 to 2030, culminating in a forecasted valuation of US$1,034.78 billion by the end of the period. The injectable drug delivery market is driven by the rising prevalence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, alongside an increasing global demand for biologics.
- Published: May 2025
- Price: $ 8150
- TOC Available:
-
North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017
The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.
- Published: April 2013
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Packaging Market by Raw Material (Plastic, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Prefilled Syringes), Drug Delivery, and Region - Global Forecast to 2030
The pharmaceutical packaging market is projected to reach USD 364.11 billion by 2030 from USD 174.86 billion in 2025, at a CAGR of 15.8% during the forecast period. The report profiles key companies, including Amcor Plc (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), AptarGroup, Inc. (US), and BD (US), which are some major players in the pharmaceutical packaging market. These players have adopted various strategies such as mergers & acquisitions, joint ventures, and expansion to strengthen their market position.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Transfection Technologies Market by Product (Kits, Equipment), Method (Physical (Electroporation, Microinjection), Biochemical (Lipofection, Calcium Phosphate), Viral), Application (Biomedical Research, Therapeutic Delivery) & Region - Global Forecast to 2028
The global transfection technologies market, valued at US$1.1 billion in 2022, stood at US$1.2 billion in 2023 and is projected to advance at a resilient CAGR of 9.4% from 2023 to 2028, culminating in a forecasted valuation of US$1.8 billion by the end of the period. The growth of this market is largely driven by the increased R&D investments and growing need of cell-based therapies. Furthermore, increased research activities for drug discovery and development, the transfection technologies have seen substantial expansion over the last decade.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
ePrescribing Market by Product & Services (Solution (Integrated, Standalone), Services (Implementation, Network)), Delivery Mode (Web & Cloud based, On premise) End User (Hospitals, Physician Offices, Pharmacies) & Region - Global Forecast to 2025
The global ePrescribing market growth is primed to transition from $1.2 billion in 2020 to $3.3 billion by 2025, showcasing a strong CAGR of 23.3%. Factors such as the increasing adoption of EHR solutions, government initiatives and incentive programs, rising focus on reducing the abuse of controlled substances, increasing focus on reducing medical errors, and the need to curtail the escalating healthcare costs are driving the growth of the e-prescribing market.
- Published: August 2020
- Price: $ 4950
- TOC Available:
-
Learning Management System Market by Delivery Mode (Distance Learning, Instructor-led Learning, Blended Learning), Application Area (Corporate Training & Development, Professional Certification & Compliance, Course Management) - Global Forecast to 2028
The LMS market size is projected to reach USD 51.9 billion by 2028 at a Compound Annual Growth Rate (CAGR) of 18.6% during the forecast period. Some of the key players operating in the learning management system market are – Anthology (US), Moodle (Australia), Cornerstone OnDemand (US), D2L Corporation (Canada), Instructure Inc. (US), PowerSchool (US), IBM (US), Infor (US), Adobe (US), LTG (UK), Google (US), Oracle (US), SAP (Germany), Docebo (Canada), Learning Pool (UK), Absorb LMS (Canada), CrossKnowledge (France), BizLibrary(US), iSpring (US), Blue Sky eLearn (US), Trakstar (US), DigitalChalk (US), Touvti LMS (US), SkyPrep (Canada), Talent LMS (US), Acorn LMS (Australia), and LearnWorlds (UK).
- Published: February 2024
- Price: $ 7150
- TOC Available:
-
Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029
The global pharmaceutical drug delivery market, valued at US$1,831.1 million in 2023, stood at US$1,949.4 million in 2024 and is projected to advance at a resilient CAGR of 5.5% from 2024 to 2029, culminating in a forecasted valuation of US$2,546.0 million by the end of the period. The increasing patient population with chronic diseases, coupled with the growing geriatric population, rising technological advancements in pharmaceutical drug delivery products offering enhanced patient convenience and compliance, the growing adoption of home-based and self-administration, rising government initiatives promoting accessibility to pharmaceutical drug delivery, and the increasing demand for biosimilars and biologics are likely to support market growth.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application (Diagnostics (Clinical, PoC), Research (Proteomic, Genomics, Cell), Therapeutics (Drug Delivery, Wearables)), End User- Global Forecast to 2029
The global microfluidics market, valued at US$21.36 billion in 2023, stood at US$22.43 billion in 2024 and is projected to advance at a resilient CAGR of 7.8% from 2024 to 2029, culminating in a forecasted valuation of US$32.67 billion by the end of the period. The rising requirement of point-of-care diagnostics is an important factor, that helps to detect cancer, infectious diseases, and chronic illnesses, for which microfluidic devices are preferred due to their accuracy.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Patient Access Solutions Market by Product & Service (Training, Education, Medical Necessity, Pre-certification), Delivery Mode (Web & Cloud, On premise), End User (Providers, Healthcare BPO Service Providers) - Global Forecast to 2027
The global patient access solutions market is primed to transition from $1.9 billion in 2022 to $2.9 billion by 2027, showcasing a strong CAGR of 8.9%. The factors driving market growth include the need to maintain regulatory compliance, rising need to curtail healthcare costs, rising importance of denials management. However, dearth of skilled IT professionals, and high deployment costs is challenging the growth of the global patient access solutions market to a certain extent.
- Published: August 2022
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
